News & Updates
Filter by Specialty:
HK data: Long-acting injectable antipsychotics safer, more effective than oral antipsychotics for schizophrenia
Long-acting injectable antipsychotics (LAIAs) for schizophrenia are associated with lower risks of disease relapse, hospitalizations, and suicide attempts vs oral antipsychotics (OAs), without an increased risk of adverse events (AEs), according to a 16-year population-based self-controlled case series (SCCS) study by the University of Hong Kong.
HK data: Long-acting injectable antipsychotics safer, more effective than oral antipsychotics for schizophrenia
29 Aug 2022Pimavanserin trumps atypical antipsychotics in preventing death in Parkinson’s disease patients
Use of pimavanserin appears to be more effective than atypical antipsychotic agents in reducing mortality among Parkinson’s disease patients during the first 180 days of treatment, reveals a study. However, such benefit is seen only in community-dwelling patients and not in nursing home residents.
Pimavanserin trumps atypical antipsychotics in preventing death in Parkinson’s disease patients
26 Aug 2022Use of antipsychotics, but not opioids, drops in nursing home residents with dementia
Prescription of antipsychotic and anxiolytic medications has decreased among residents with dementia in Veterans Health Administration (VHA) nursing homes, but overall prescribing of other psychotropic and opioid agents has increased, reports a study.
Use of antipsychotics, but not opioids, drops in nursing home residents with dementia
25 Aug 2022Relapse prevention interventions effective in MDD
In patients with remitted major depressive disorder (MDD), the use of psychological relapse prevention interventions, whether as a standalone or in combination with medication, effectively reduces the risk of relapse/recurrence, according to a recent meta-analysis.
Relapse prevention interventions effective in MDD
24 Aug 2022Poor mental health raises risk of incident T2D
People with worse overall psychological wellbeing are at significantly higher risk of developing type 2 diabetes (T2D) in a dose‒response manner irrespective of their genetic predisposition, suggest the results of a recent study.
Poor mental health raises risk of incident T2D
18 Aug 2022Psychotherapy for alcohol use disorder extends benefit to alcohol-related liver disease
Undergoing psychotherapy for alcohol use disorder (AUD) helps prevent the incidence and progression of alcohol-associated liver disease (ALD), according to a study.
Psychotherapy for alcohol use disorder extends benefit to alcohol-related liver disease
18 Aug 2022Meta-analysis: “Sunshine vitamin” may brighten mood
Vitamin D is known for its role in bone ossification, and most of this vitamin is made when skin is exposed to sunlight. Recently, a meta-analysis has reported that supplemental vitamin D can help alleviate depressive symptoms in adults.
Meta-analysis: “Sunshine vitamin” may brighten mood
17 Aug 2022Labour epidural analgesia not a risk factor for offspring ASD, ADHD
Children born to mothers who were exposed to labour epidural analgesia do not appear to be at greater risk of autism spectrum disorder (ASD) or attention-deficit/hyperactivity disorder (ADHD), according to a study.